â– LECTURE OVERVIEW: Neonatal Respiratory Distress Syndrome (RDS) is a major cause of respiratory distress in premature infants, most commonly caused by surfactant deficiency.
â– MOLECULAR PHYSICS & COLLAPSE:
1. Type II pneumocytes: Synthesize surfactant, a phospholipid-rich substance (primarily dipalmitoylphosphatidylcholine), starting around 28 weeks gestation.
2. Surface Tension: Surfactant coats alveoli, reducing surface tension.
3. Laplaces Law (P = 2T/r): In surfactant deficiency, high surface tension (T) causes small alveoli to experience high pressure (P), collapsing into them (atelectasis) on expiration.
4. Intrapulmonary Shunt: Alveolar collapse causes ventilation-perfusion mismatch, leading to hypoxia, hypercapnia, and acidosis.
5. Hyaline Membranes: Acidosis damages endothelial tissues, spilling fibrin-rich fluid that forms pink hyaline membranes on histology.
â– RADIOGRAPHIC DIAGNOSTIC CRITERIA:
Imaging modalities (such as high-resolution CT, contrast-enhanced MRI, and point-of-care ultrasound) show characteristic density shifts, enhancement patterns, or structural deviations.
â– GENOMIC VARIANT CHARACTERISTICS:
Molecular profiling indicates that specific genetic subtypes exhibit varying levels of enzyme activity and drug-clearance efficiency.
[HY-BOARD-1117]
🌟 Dynamic Clinical Key:
Presents at birth with tachypnea, nasal flaring, grunting, and intercostal retractions. Chest X-ray reveals a classic ground-glass appearance with air bronchograms. Incidence is reduced by giving antenatal corticosteroids (Dexamethasone) before preterm delivery to mature type II cells. Always correlate imaging signs with clinical presentation to avoid unnecessary surgical explorations of benign incidentalomas. Genetic screening profiles can help tailor precise therapeutic doses for optimal patient outcomes.